Introduction 5 8
The COP9 signalosome (CSN) is a highly conserved protein complex formed by 8 unique 1 0 0 membrane which will lead to the cell swelling and plasma membrane rupture. 11 Ubiquitination 1 0 1 plays an essential role in the regulation of both the kinase activity of RIPK1 and the activation of RIPK1 mediates its proteasomal degradation. 14, 15 Cullin3 (Cul3)-based polyubiquitination of 1 0 6 caspase 8 drives full activation and processing of caspase 8, which leads to activation of the 1 0 7 extrinsic apoptotic pathway. 16 However, it remains unclear how the malfunction of the CSN, a 1 0 8 major regulator of CRLs, impacts these cell death pathways although ablation of various Cops 1 0 9 genes and the chemical inhibition of the CSN are known to induce cell death. 7-9, 17, 18 1 1 0
Loss of the cardiomyocyte (CM) as a result of apoptosis and/or various forms of 1 1 1 regulated necrosis contributes to heart failure, 11, 19 a leading cause of disability and 1 1 2 death in humans. Findings from analyzing biochemical markers of necroptosis in the 1 1 3 myocardium of humans with end-stage heart failure resulting from myocardial infarction (MI) or for subsequent protein analyses, or perfusion-fixed in situ for histopathological assessment. Detection of CM necrosis in mouse hearts was performed as reported. 8 In brief, at 3 weeks of age 1 8 0 when the homozygous Cops8 CKO mice begin to show massive CM necrosis, 7 mice were injected 1 8 1 with EBD (100 mg/kg, i.p.). Eighteen hours after injection, the mice were anesthetized via 1 8 2 isoflurane inhalation; in situ retrograded perfusion-fixation via the abdominal aorta was carried 1 8 3 out sequentially with 0.9% normal saline and 3.8% paraformaldehyde dissolved in phosphate-1 8 4 buffered saline (PBS). The atria were trimmed, and the fixed ventricles were processed for OCT 1 8 5 embedding and subjected to cryosectioning. A series of 7-µm cryosections were collected from 1 8 6 the base to the apex of the ventricles. One in every 50 sections was stained for F-actin with 1 8 7
Alexa-488 conjugated phalloidin to identify CMs and subjected to imaging with a confocal 1 8 8 microscope (Olympus Fluoview 500). The images of each ventricular tissue ring were The co-immunoprecipitation was performed as previously described. 35 In brief, protein A/G 2 3 3 PLUS-Agarose beads (sc-2003, Santa Cruz Biotechnology Inc., USA) were washed with a buffer 2 3 4 (WGB buffer) containing 0.05M Hepes, 0.15M NaCl, and 1% Triton X-100 (pH 7.6) 3 times 2 3 5 before being incubated with either anti-RIPK1 antibodies or control IgG for 2 hours at room 2 3 6 temperature. The beads were then incubated at 4 overnight with the crude proteins extracted 2 3 7 from ventricular myocardium in the radioimmunoprecipitation assay (RIPA) buffer. The beads 2 3 8 were then spun down, separated from supernatant, and further washed 3 times (5 min per wash) with the WGB buffer to remove unbound proteins; proteins bound on the beads were then eluted 2 4 0 with SDS loading buffer (50 mM Tris-HCl at pH 6.8, 2% SDS, and 10% glycerol) and then 2 4 1 boiled for 5 min. The eluted proteins were subjected to SDS-PAGE and western blot analyses for 2 4 2 RIPK1 and RIPK3 with the western blot protocol as described above. Protein carbonyl assays used the Oxidized Protein Western Blot Detection Kit (ab178020; 2 4 5 Abcam, USA) and were performed as we previously described. 36 Briefly, ventricular 2 4 6 myocardium was homogenized in RIPA buffer. After centrifugation, the supernatant was 2 4 7 collected and supplemented with DTT (50 mM, final concentration). Protein samples were then 2 4 8 mixed with the same volume of 12% SDS and incubated with an equal volume of the 1× 2,4- with an anti-DNP antibody. The activities of caspase 8 in myocardial crude protein extracts were measured using the Caspase-8 Colorimetric Assay Kit (K113, BioVision, Inc., USA). The presentation of quantitative data and the methods for statistical analyses are described in the 2 6 0 legend of each figure. We have previously observed massive CM necrosis in mice with Cops8 CKO initiated at either the 2 6 4 perinatal or adult stage. 7, 9 To explore the mechanism governing the CM necrosis in Cops8 2 6 5 deficient hearts, we examined the potential involvement of the RIPK1-RIPK3 pathway. Western 2 6 6 blot analyses revealed marked increases in myocardial protein levels of RIPK1, RIPK3, and 2 6 7 MLKL in mice with perinatal Cops8 CKO compared with littermate control mice (Figure 1A, 1B ).
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Co-immunoprecipitation of RIPK1 detected increased association of RIPK3 with RIPK1 in 2 6 9
Cops8 CKO hearts compared with littermate controls (Figure 1C, 1D) . Increased RIPK1-RIPK3 2 7 0 interaction is a key step in the activation of the necroptotic pathway by death receptor 2 7 1 engagement; 37-39 hence, these data suggest that the RIPK1-RIPK3 pathway is likely activated in 2 7 2
Cops8 deficient hearts. To determine whether RIPK1 kinase activity is required for CM necrosis in Cops8 CKO hearts, we 2 7 6 tested the impact of necrostatin-1 (Nec-1), a RIPK1 kinase-specific inhibitor. 40 Since CM 2 7 7 necrosis is detectable at 3 weeks of age, but not at 2 weeks, the administration of Nec-1 or 2 7 8 vehicle control via intraperitoneal implantation of osmotic mini-pumps was initiated in Cops8 CKO 2 7 9 mice at 2 weeks of age. CM necrosis was assessed with the in vivo EBD uptake assay in the 2 8 0 heart harvested 7 days after mini-pump implantation. EBD positive CMs were not detectable in (Figure 2A, 2B , p<0.0001), indicating that RIPK1 kinase activity is required for 2 8 5
Cops8 deficiency to induce CM necrosis in mice. Moreover, Kaplan-Meier survival analyses providing compelling evidence that RIPK3 is required for CM necrosis in Cops8 CKO mice. The 3 0 0 findings described so far also demonstrate that CM necrosis induced by Cops8 deficiency 3 0 1 belongs to necroptosis and is mediated primarily by the RIPK1-RIPK3 pathway. Since necroptosis was originally observed in TNFα-treated cells whose caspase 8 is defective or with heterozygous Cops8 CKO and Cops8 FL/FL littermates (p=0.0102, 0.0003; Figure 7D ).
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Myocardial BCL2 mRNA levels were also greater in homozygous Cops8 CKO mice than littermate 3 5 7 controls at both 2 and 3 weeks of age ( Figure 7E) . Taken together, these data support that Cops8 Increased oxidative stress is known to activate the nuclear factor E2-related factor 2 (Nrf2). Indeed, our prior transcriptome analysis has revealed that Nrf2 target genes are markedly 3 6 2 upregulated in Cops8 CKO hearts. 43 Here our further work detected that myocardial protein levels 3 6 3 of total Nrf2 and Ser40-phosphorylated Nrf2 (pS40-Nrf2) were significantly increased in 3 6 4
Cops8 CKO mice at 2 and 3 weeks of age, compared with littermate controls (Figure 8A~8C ).
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Phosphorylation of Nrf2 by protein kinase C (PKC) at Ser40 is known to promote Nrf2 nuclear 3 6 6 translocation and increase its target gene expression; 44 hence, the increases in pS40-Nrf2 are 3 6 7 consistent with increased Nrf2 transactivation in Cops8 deficient hearts as we previously To test the role of increased Nrf2 in the CM necroptosis, we crossbred the Nrf2-floxed necroptosis in Cops8 CKO mice. This is because Cyclophilin D knockout, which is known to 4 0 5 inhibit MPT, did not attenuate but rather exacerbated CM necrosis and premature death in 4 0 6
Cops8 CKO mice (Figure 4) . Cops8 CKO in mice. anti-tumor effects in experimental studies. 18 Hence, there is a good possibility for this compound 5 1 3
to move into clinical trials for the treatment of cancer. CSN5i is expected to affect the 5 1 4 degradation of a much smaller range of proteins than proteasome inhibitors would while being 5 1 5 equally or even more effective in blocking cell cycle progression and causing cell death. The CSN5i or alike be moved into clinical trials. Lastly yet importantly, because of the wealth of various pathological stresses in different organs, such as lungs, livers, kidneys, and the heart,
Nrf2 has evolved to be an attractive drug target for the prevention or treatment of human diseases including heart failure. 59, 60 However, a phase III clinical trial of bardoxolone methyl, an Nrf2 5 2 2 inducer, for the treatment of chronic renal disease associated with diabetes was terminated due to 5 2 3 significantly increased incidence of heart failure. 61 It is unclear whether the "dark" side of Nrf2 5 2 4
is linked to the magnitude of Nrf2 activation 62 or simply due to off-target effects of the drug.
2 5
Notably, a number of clinical trials at various phases on Nrf2 inducers for treating several other 5 2 6
forms of disease (e.g., multiple sclerosis, cancers, pulmonary artery hypertension) are still 5 2 7
ongoing; hence, elucidation of the mechanism governing the dark side of Nrf2 activation on the 5 2 8
heart is absolutely warranted. To this end, the discovery of the present study that sustained Nrf2 5 2 9
activation and reductive stress promote CM necroptosis in a heart with impaired functioning of 5 3 0 autophagy and the UPS may provide a previously unsuspected mechanism for the adverse 5 3 1 cardiac effect of Nrf2 inducers. In conclusion, the present study has discovered that CM necrosis in Cops8 CKO mice belongs to that Cops8/the CSN by virtue of cullin deneddylation suppresses necroptosis and plays a crucial cause CM necroptosis is illustrated in Figure 8E . In brief, loss of cullin deneddylation resulting formation of the RIPK1-or RIPK1-RIPK3-centered complex 2 become inevitable. Since is disabled when cullin deneddylation is shut down; hence, the RIPK1-RIPK3 complex takes its β -Tubulin and α -actinin were probed as loading controls for the proteins shown above. Mean with SEM, *p<0.05, **p<0.01 vs. CTL; C, Western blot (IB) analyses for RIPK1 and RIPK3 in the RIPK1 immuno-precipitates (IP) from the protein lysate of ventricular myocardium from 3-week-old CTL and Cops8 CKO mice. One mouse/lane. L929 cell lysates were used as positive controls. D, RIPK1/RIPK1 ratios in the RIPK1 IP. The density of RIPK3 and RIPK1 bands for individual samples shown in panel C was used for the calculation of RIPK3 to RIPK1 ratios, the mean of the ratios of the CTL group is defined as 1 arbitrary unit (AU). The p values shown in this figure are derived from two-side unpaired t-test with Welch's correction.
Figure 2.
Necrostatin-1 (Nec-1) treatment markedly reduces CM necrosis and delays premature death of Cops8 CKO mice. Cohorts of Cops8 CKO mice at 2 weeks of age were treated with necrostatin-1 (Nec-1, 1.56 mg/kg/day) or vehicle (Veh) via intraperitoneal osmatic minipumps for 1 week (A, B) or continued for >2 weeks for the Kaplan-Meier survival analysis (C). A and B, At day 6, after min-pump implantation, mice were treated with one dose of Evan's blue dye (EBD; 100 mg/kg, i.p.) 18 hours before they were anesthetized and perfusion-fixed in situ. Cryosections from the fixed heart were stained with Alexa488-conjugated phalloidin to identify CMs (green) and subjected to fluorescence confocal imaging analyses. The images of each ventricular tissue ring were reconstructed and used for quantification of EBD-positive area (red) and total green area. Panel α -Actinin was probed as a loading control. Shown are representative images (C) and pooled densitometry data (D). Mean±SEM are superimposed. Cre, Myh6-Cre TG only; ***p =0.0002 vs. Cre, one way ANOVA followed by Bonferroni's multiple comparisons test. E, Representative image of western blot analysis of DNP-derivatized protein carbonyls. The opening curly brace demarcates the protein molecular weight range where carbonyls were increased most in the Hom-KO group. NC, negative control where equal amount of myocardial proteins that were not subject to DNP derivatization was loaded. and pooled quantitative data (B) from the EBD uptake assays for LV myocardium of Cops8 CKO mice treated with NAC or vehicle control. Seven consecutive daily intraperitoneal injections of NAC (100 mg/kg/day) or vehicle were initiated at 14 days of age. EBD assays were performed at 21 days of age as described in Figure 2 . EBD positive CMs emit autofluorescence (red); Alexa fluor-488-conjugated phalloidin was used to stain F-actin and thereby identify cardiomyocytes (green). In the dot plot (B), individual percent values of average EBD positive area are shown. Four representative sections/mouse and 5 mice/group were included. Median with range, p=0.0167, Mann Whitney test. C, Kaplan-Meier survival curve of mice of the indicated genotypes. Both males and females (roughly 1:1 ratio) were included. Log-rank test.
Figure 7. Changes in both protein expression and activities of caspases 8 as well as BCL2
protein and mRNA levels in Cops8 CKO mouse hearts. A and B, Representative images (A) and scatter dot plots of pooled densitometry data (B) of western blot analyses for caspase 8 (Casp8). L.C., Loading control which is a portion of the image from stain-free in-gel imaging of total proteins that was used to normalize caspase 8 western blot signals. F-, full length; C-, cleaved form. C, Changes in myocardial caspase 8 activities in Cops8 CKO mice at 3 weeks. CTL, littermate control; KO, homozygous Cops8 CKO . D, Representative images of western blot analyses for myocardial BCL2 in homozygous Cops8 FL/FL (Floxed), heterozygous Cops8 CKO (Het-CKO), and homozygous Cops8 CKO (Hom-CKO) mice at 3 weeks of age. E, Changes in myocardial BCL2 mRNA levels in mice at 2 and 3 weeks of age. Each scatter dot plot is superimposed by mean±SD; each dot represents a mouse; p values are derived from unpaired t-tests with Welch's correction (B, C) or one way ANOVA followed by Tukey's test (E).
Figure 8. The Nrf2-BCL2 pathway is activated and contributes to CM necroptosis in
Cops8 CKO mouse hearts. A ~ C, representative images (A) and the summary of densitometry data (B, C) of western blot analyses for the indicated proteins in the ventricular myocardium of mice of the indicated genotypes at 2 and 3 weeks of age. Here CTL are comprised of Myh6-Cre TG mice. One way ANOVA followed by Tukey's test. D, Kaplan-Meier survival curve of littermate mice of the indicated genotypes. The median lifespan for Cops8 CKO mice in the heterozygous Nrf2 CKO background (Cops8 FL/FL ::Nrf2 FL/WT ::Myh6-Cre) or in the wild type Nrf2 background (Cops8 FL/FL ::Myh6-Cre) is respectively 28 or 24 days. Log-rank test. Both male and female (roughly 1:1 ratio) were included in all studies. E, A working model for induction of CM necroptosis by Cops8 deficiency, with the main interrogations of this study marked with bold black font. Casp8, caspase 8; dot line denotes a potential link that is not tested yet.
